FDA just authorized a breakthrough coronavirus drug that’s proven to save lives
The FDA authorized Eli Lilly's bamlanivimab, a monoclonal antibody drug, for mild-to-moderate COVID-19 treatment. It blocks the virus from infecting cells and is most effective when administered early. Not for hospitalized patients. Administered intravenously, it aims to prevent severe complications and reduce death risk.
Reference News
FDA just authorized a breakthrough coronavirus drug that’s proven to save lives
The FDA authorized Eli Lilly's bamlanivimab, a monoclonal antibody drug, for mild-to-moderate COVID-19 treatment. It blocks the virus from infecting cells and is most effective when administered early. Not for hospitalized patients. Administered intravenously, it aims to prevent severe complications and reduce death risk.